[go: up one dir, main page]

BR9802360A - "semaforina l (h-semal) humana e semaforinas correspondentes em outras espécies". - Google Patents

"semaforina l (h-semal) humana e semaforinas correspondentes em outras espécies".

Info

Publication number
BR9802360A
BR9802360A BR9802360-8A BR9802360A BR9802360A BR 9802360 A BR9802360 A BR 9802360A BR 9802360 A BR9802360 A BR 9802360A BR 9802360 A BR9802360 A BR 9802360A
Authority
BR
Brazil
Prior art keywords
semaphorins
domain
new
semal
species
Prior art date
Application number
BR9802360-8A
Other languages
English (en)
Inventor
Bernhard Fleckenstein
Armin Ensser
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1997129211 external-priority patent/DE19729211C2/de
Priority claimed from DE1998105371 external-priority patent/DE19805371A1/de
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of BR9802360A publication Critical patent/BR9802360A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Patente de Invenção:<B>"SEMAFORINA l (H-SemaL) HUMANA E SEMAFORINAS CORRESPONDENTES EM OUTRAS ESPéCIES"<D>. A invenção refere-se a novas semaforinas que são distinguidas por uma estrutura de domínio específica e derivados da mesma, ácidos nucleicos (DNA, RNA, cDNA) que codificam estas semaforinas e derivados das mesmas, e a utilização das mesmas. A presente invenção refere-se a semaforinas que possuem uma estrutura de domínio nova, ainda não revelada e inesperada e que possuem uma função no sistema imune (semaforinas imunomodulantes). As novas semaforinas são referidas como semaforinas do tipo L (Sema-L). Elas compreendem um período de sinal de terminal N, um domínio Sema característico e, na região terminal C da proteína, um domínio semelhantes a imunoglobulina e um domínio hidrofóbico que representa um domínio de transmembrana em potencial.
BR9802360-8A 1997-07-09 1998-07-08 "semaforina l (h-semal) humana e semaforinas correspondentes em outras espécies". BR9802360A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997129211 DE19729211C2 (de) 1997-07-09 1997-07-09 Humanes Semaphorin L (H-Sema-L) und korrespondierende Semaphorine in anderen Spezies
DE1998105371 DE19805371A1 (de) 1998-02-11 1998-02-11 Humanes Semaphorin L (H-Sema-L) und korrespondierende Semaphorine in anderen Spezies

Publications (1)

Publication Number Publication Date
BR9802360A true BR9802360A (pt) 1999-10-05

Family

ID=26038116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9802360-8A BR9802360A (pt) 1997-07-09 1998-07-08 "semaforina l (h-semal) humana e semaforinas correspondentes em outras espécies".

Country Status (15)

Country Link
US (2) US20020037851A1 (pt)
EP (1) EP0892047A3 (pt)
JP (1) JPH11235189A (pt)
KR (1) KR19990013797A (pt)
CN (1) CN1209436A (pt)
AR (1) AR013190A1 (pt)
AU (1) AU744447B2 (pt)
BR (1) BR9802360A (pt)
CA (1) CA2237158A1 (pt)
CZ (1) CZ214998A3 (pt)
HU (1) HUP9801511A3 (pt)
ID (1) ID20819A (pt)
PL (1) PL327385A1 (pt)
RU (1) RU2218181C2 (pt)
TR (1) TR199801301A3 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232899B2 (en) 1996-09-25 2007-06-19 The Scripps Research Institute Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
EP1066317A2 (en) * 1998-01-30 2001-01-10 Smithkline Beecham Plc Novel compounds
AU2982799A (en) * 1998-03-03 1999-09-20 Zymogenetics Inc. Human semaphorin zsmf-7
WO1999058676A2 (en) * 1998-05-14 1999-11-18 Immunex Corporation Semaphorin polypeptides
IL144060A0 (en) * 1999-01-14 2002-04-21 Novartis Ag Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
AU2002359446B2 (en) * 2001-11-09 2008-12-04 Georgetown University Novel isoforms of vascular endothelial cell growth inhibitor
JP2005173484A (ja) * 2003-12-15 2005-06-30 Canon Inc 画像形成装置及びプロセスカートリッジ
UA96139C2 (uk) * 2005-11-08 2011-10-10 Дженентек, Інк. Антитіло до нейропіліну-1 (nrp1)
FR2932388B1 (fr) * 2008-06-17 2013-03-29 Univ Rabelais Francois Nouvelles proteines de fusion et leur application pour la preparation de vaccins contre l'hepatite c
MX2011011718A (es) 2009-05-08 2012-01-27 Vaccinex Inc Anticuerpos anti-cd100 y metodos para su uso.
US20130095118A1 (en) * 2011-10-11 2013-04-18 Vaccinex, Inc. Use of Semaphorin-4D Binding Molecules for Modulation of Blood Brain Barrier Permeability
US9090709B2 (en) 2012-03-28 2015-07-28 Vaccinex, Inc. Anti-SEMA4D antibodies and epitopes
US10494440B2 (en) 2012-05-11 2019-12-03 Vaccinex, Inc. Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
EP3013350B1 (en) 2013-06-25 2020-01-08 Vaccinex, Inc. Use of semaphorin-4d inhibitory molecules in combination with an immune modulating therapy to inhibit tumor growth and metastases
NZ630881A (en) 2013-10-10 2016-03-31 Vaccinex Inc Use of semaphorin-4d binding molecules for treatment of atherosclerosis
NZ630892A (en) 2013-10-21 2016-03-31 Vaccinex Inc Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
CN104034761B (zh) * 2014-05-14 2017-01-04 浙江大学 一种检测气味结合蛋白与信息素结合过程的装置及方法
SG11201906670PA (en) * 2017-02-22 2019-08-27 Vaccinex Inc Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639856A (en) * 1993-09-13 1997-06-17 The Regents Of The University Of California Semaphorin gene family
US5416197A (en) * 1993-10-15 1995-05-16 Trustees Of The University Of Pennsylvania Antibodies which bind human collapsin
EP1066317A2 (en) * 1998-01-30 2001-01-10 Smithkline Beecham Plc Novel compounds
AU2982799A (en) * 1998-03-03 1999-09-20 Zymogenetics Inc. Human semaphorin zsmf-7
US6225285B1 (en) * 1998-03-11 2001-05-01 Exelixis Pharmaceuticals, Inc. Semaphorin K1
WO1999058676A2 (en) * 1998-05-14 1999-11-18 Immunex Corporation Semaphorin polypeptides
EP1803730A1 (en) * 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albumin fusion proteins

Also Published As

Publication number Publication date
PL327385A1 (en) 1999-01-18
US20020037851A1 (en) 2002-03-28
EP0892047A3 (de) 2000-03-08
US7339030B2 (en) 2008-03-04
ID20819A (id) 1999-03-11
AU744447B2 (en) 2002-02-21
CZ214998A3 (cs) 1999-01-13
CN1209436A (zh) 1999-03-03
RU2218181C2 (ru) 2003-12-10
HUP9801511A3 (en) 2001-08-28
TR199801301A2 (xx) 1999-01-18
HUP9801511A2 (hu) 1999-05-28
HU9801511D0 (en) 1998-09-28
EP0892047A2 (de) 1999-01-20
AR013190A1 (es) 2000-12-13
US20060029998A1 (en) 2006-02-09
JPH11235189A (ja) 1999-08-31
TR199801301A3 (tr) 1999-01-18
AU7507698A (en) 1999-01-21
KR19990013797A (ko) 1999-02-25
CA2237158A1 (en) 1999-01-09

Similar Documents

Publication Publication Date Title
BR9802360A (pt) &#34;semaforina l (h-semal) humana e semaforinas correspondentes em outras espécies&#34;.
Singh et al. Lectins from red algae and their biomedical potential
Wesley et al. Neutral and acidic species of human intestinal mucin. Evidence for different core peptides.
DE69013342T2 (de) Menschliche lactoferrin-cdna-sequenz.
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE69638022D1 (de) Aus wirbeltieren und darauf basierende verfahren
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
BR0109494A (pt) Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas
DE69638023D1 (de) Nukleotid- und proteinsequenzen von delta-genen von vertebraten und darauf basierende methoden
BR9611210A (pt) Composições e processos para tratamento de condições ósseas deficitárias
DK0808367T3 (da) Vaskulære slimhindeaddressiner samt anvendelse deraf
BR9809914A (pt) Genes de moracella receptores de lactoferrina
AR023099A1 (es) Constructos de adn que codifican saratina y sus usos.
ATE326478T1 (de) Peptidderivat
HERRLER et al. N-Acetyl-9-0-acetylneuraminic acid, the receptor determinant for influenza C virus, is a differentiation marker on chicken erythrocytes
BR9812394A (pt) Amino terminalmente truncado mcp-2 como antagonistas da quimiocina
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
PRIMOR et al. Pardaxin: the toxic factor from the skin secretion of the flatfish Pardachirus marmoratus (Soleidae)
Eyre et al. Comparative biochemistry of collagen crosslinks: Reducible bonds in invertebrate collagens
AR029627A1 (es) Derivados de proteina c y composiciones farmaceuticas formuladas con dichos derivados, moleculas de dna recombinante que codifican dichos derivados; vectores de transformacion que comprenden dichos derivados; aislados de acidos nucleicos que comprenden polinucleotidos que codifican al menos el 90% d
Bell et al. The N-terminus of PE2 in Sindbis virus-infected cells
CO4410257A1 (es) Vacuna de polinucleotido de herpes virus
Goto et al. Purification and characterization of an agglutinin of the soft coral Sinularia species
BR9708005A (pt) C3 convertase resistente à regulação para baixo
Kaufman et al. Mechanism and characteristics of coxal fluid excretion in the argasid tick Ornithodorus moubata

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A,9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1894 DE 24/04/2007.